European Journal of Cancer最新文献

筛选
英文 中文
Digital Interventions for psychosocial risk factors in cancer onset: Systematic review for the iBeChange platform 癌症发病中心理社会风险因素的数字化干预:iBeChange平台的系统综述
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116344
M. Masiero , E. Tomezzoli , C. Marzorati , G. Pagani , R. Pietrobon , S. Mattioli , L. Teixeira , M. Serra-Blasco , A. García-Serra , C. Ochoa- Arnedo , D. Monzani , B. Caci , G. Miale , G. Pravettoni
{"title":"Digital Interventions for psychosocial risk factors in cancer onset: Systematic review for the iBeChange platform","authors":"M. Masiero , E. Tomezzoli , C. Marzorati , G. Pagani , R. Pietrobon , S. Mattioli , L. Teixeira , M. Serra-Blasco , A. García-Serra , C. Ochoa- Arnedo , D. Monzani , B. Caci , G. Miale , G. Pravettoni","doi":"10.1016/j.ejca.2026.116344","DOIUrl":"10.1016/j.ejca.2026.116344","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116344"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147554917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health education in the digital age: Analysing the engagement and impact of breast cancer content on TikTok 数字时代的健康教育:TikTok上乳腺癌内容的参与度和影响分析
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116345
L. Chandrakumar , I. Carty , D. Betal
{"title":"Health education in the digital age: Analysing the engagement and impact of breast cancer content on TikTok","authors":"L. Chandrakumar , I. Carty , D. Betal","doi":"10.1016/j.ejca.2026.116345","DOIUrl":"10.1016/j.ejca.2026.116345","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116345"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147554918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer 免疫治疗驱动的腋窝分期降低和三阴性乳腺癌手术降级的真实证据
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116357
L. Pitoni , A.J. Esgueva Colmenarejo , C. Siso Raber , F. Martinez Regueira , N. Rodriguez-Spiteri , B. Olartecoechea , C. Sobrido , L.J. Pina , T. Iscar , A. Lopez Janeiro , I.T. Rubio
{"title":"Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer","authors":"L. Pitoni , A.J. Esgueva Colmenarejo , C. Siso Raber , F. Martinez Regueira , N. Rodriguez-Spiteri , B. Olartecoechea , C. Sobrido , L.J. Pina , T. Iscar , A. Lopez Janeiro , I.T. Rubio","doi":"10.1016/j.ejca.2026.116357","DOIUrl":"10.1016/j.ejca.2026.116357","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116357"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147554122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac decision impact (CarDI) study for cardiovascular disease risk identification in breast cancer patients undergoing radiotherapy: Protocol of a clinical trial 乳腺癌放疗患者心血管疾病风险识别的心脏决策影响(CarDI)研究:一项临床试验方案
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116342
S. Jaya-Prakason , E. Benkel , B.B. Irankunda , F. Banning , R. Kates , S.A.M. Gernaat , M.V. Maraldo , E. Batista , H.J.G.D. van den Bongard , T. Spanic , H.M. Verkooijen , N. Harbeck
{"title":"Cardiac decision impact (CarDI) study for cardiovascular disease risk identification in breast cancer patients undergoing radiotherapy: Protocol of a clinical trial","authors":"S. Jaya-Prakason , E. Benkel , B.B. Irankunda , F. Banning , R. Kates , S.A.M. Gernaat , M.V. Maraldo , E. Batista , H.J.G.D. van den Bongard , T. Spanic , H.M. Verkooijen , N. Harbeck","doi":"10.1016/j.ejca.2026.116342","DOIUrl":"10.1016/j.ejca.2026.116342","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116342"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147554915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a telephone-based weight loss intervention on overall dietary quality and dietary lipids intake in overweight and obese breast cancer (BC) survivors: secondary analyses from the MEDEA randomized controlled trial (RCT) 电话减肥干预对超重和肥胖乳腺癌(BC)幸存者总体饮食质量和饮食脂质摄入的影响:来自MEDEA随机对照试验(RCT)的二次分析
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116377
S. Maccarone , H. Julie , E. Martin , R. Gazan , M. Maillot , D. Soldato , B. Raynard , C. Tracy E , A. Barbier , A. Mangin , B. Pistilli , L. Vanlemmens , C. Segura-Djezzar , C. Bouleuc , O. Tredan , S. Michiels , D. Chaltiel , J.A. Ligibel , I. Vaz-Luis , A. Di Meglio
{"title":"Impact of a telephone-based weight loss intervention on overall dietary quality and dietary lipids intake in overweight and obese breast cancer (BC) survivors: secondary analyses from the MEDEA randomized controlled trial (RCT)","authors":"S. Maccarone , H. Julie , E. Martin , R. Gazan , M. Maillot , D. Soldato , B. Raynard , C. Tracy E , A. Barbier , A. Mangin , B. Pistilli , L. Vanlemmens , C. Segura-Djezzar , C. Bouleuc , O. Tredan , S. Michiels , D. Chaltiel , J.A. Ligibel , I. Vaz-Luis , A. Di Meglio","doi":"10.1016/j.ejca.2026.116377","DOIUrl":"10.1016/j.ejca.2026.116377","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116377"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147537999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation-induced cardiac toxicity in breast cancer patients: 15 year results from a large single-center breast cancer database 乳腺癌患者的辐射诱发心脏毒性:来自大型单中心乳腺癌数据库的15年结果
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116318
A. Van Der Vorst , J. Jacobs , R. Van Lerberghe , V. De Foer , Y. Ickx , W.H. Zhan , L. Delombaerde , A. Laenen , G. Defraene , M. Lambrecht , L. Van Aelst , J. Verhoeven , A. Baten , H. Janssen , C. Weltens
{"title":"Radiation-induced cardiac toxicity in breast cancer patients: 15 year results from a large single-center breast cancer database","authors":"A. Van Der Vorst , J. Jacobs , R. Van Lerberghe , V. De Foer , Y. Ickx , W.H. Zhan , L. Delombaerde , A. Laenen , G. Defraene , M. Lambrecht , L. Van Aelst , J. Verhoeven , A. Baten , H. Janssen , C. Weltens","doi":"10.1016/j.ejca.2026.116318","DOIUrl":"10.1016/j.ejca.2026.116318","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116318"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147546700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BRAVE-HEART: Clinical and dosimetric validation of active breath control for cardiac sparing in breast cancer radiotherapy 勇敢的心:乳腺癌放疗中主动呼吸控制心脏保留的临床和剂量学验证
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116319
E. Bonzano , L. Squillace , A. Lancia , J. Saddi , S. Colombo , S. La Mattina , D.A. Santos , P. Pedrazzoli
{"title":"BRAVE-HEART: Clinical and dosimetric validation of active breath control for cardiac sparing in breast cancer radiotherapy","authors":"E. Bonzano , L. Squillace , A. Lancia , J. Saddi , S. Colombo , S. La Mattina , D.A. Santos , P. Pedrazzoli","doi":"10.1016/j.ejca.2026.116319","DOIUrl":"10.1016/j.ejca.2026.116319","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116319"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147547168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is pathological complete response a surrogate for overall survival in neoadjuvant clinical trials for gastroesophageal adenocarcinoma? 病理完全缓解是胃食管腺癌新辅助临床试验中总生存期的替代指标吗?
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-02-24 DOI: 10.1016/j.ejca.2026.116602
Luís Felipe Leite , Mariana Macambira Noronha , Samuel Menezes , Lucas Diniz da Conceição , Luiz F. Costa de Almeida , Anelise Poluboiarinov Cappellaro , Marcos Belotto , Renata D.’Alpino Peixoto , Thais Baccili Cury Megid
{"title":"Is pathological complete response a surrogate for overall survival in neoadjuvant clinical trials for gastroesophageal adenocarcinoma?","authors":"Luís Felipe Leite ,&nbsp;Mariana Macambira Noronha ,&nbsp;Samuel Menezes ,&nbsp;Lucas Diniz da Conceição ,&nbsp;Luiz F. Costa de Almeida ,&nbsp;Anelise Poluboiarinov Cappellaro ,&nbsp;Marcos Belotto ,&nbsp;Renata D.’Alpino Peixoto ,&nbsp;Thais Baccili Cury Megid","doi":"10.1016/j.ejca.2026.116602","DOIUrl":"10.1016/j.ejca.2026.116602","url":null,"abstract":"<div><h3>Background</h3><div>Pathologic complete response (pCR) is frequently used as a surrogate endpoint in neoadjuvant gastroesophageal adenocarcinoma (GEA) trials, yet its validity in predicting overall survival (OS) remains uncertain.</div></div><div><h3>Methods</h3><div>This systematic review and meta-analysis, follows PRISMA and ReSEEM guidelines, and evaluates pCR as a surrogate for OS in randomized controlled trials (RCTs) of neoadjuvant therapy for GEA. Randomized trials enrolling patients with resectable distal esophageal, gastroesophageal junction (GEJ), or gastric adenocarcinoma were included if both pCR and OS were reported. Individual-level surrogacy was assessed by correlating pCR rates with median OS across trial arms; trial-level surrogacy was evaluated by correlating treatment effects on pCR (odds ratios) with treatment effects on OS (hazard ratios) using weighted linear regression and calculating the coefficient of determination (R²).</div></div><div><h3>Results</h3><div>Twenty-six RCTs including 7452 patients were analyzed. Overall, pCR showed no meaningful correlation with OS at the individual-level (R² = 0.006; p = 0.210), and treatment effects on pCR explained little of the variability in OS effects at the trial level (R² = 0.060; p = 0.206). Most trials evaluated cytotoxic chemotherapy or chemoradiotherapy. Surrogacy varied by subgroup, being strong for esophageal adenocarcinoma (R² = 0.886; p &lt; 0.001), moderate for gastric cancer (R² = 0.386; p = 0.041), and absent for GEJ trials. Trials incorporating radiotherapy demonstrated strong surrogacy, whereas chemotherapy-only trials did not.</div></div><div><h3>Conclusions</h3><div>The interpretation of pCR results in gastroesophageal adenocarcinoma trials requires caution. Surrogacy might need to be reassessed in the upcoming immunotherapy trials.</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116602"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147316657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG 老年黑色素瘤患者的治疗模式和年龄对免疫治疗效果的影响:来自真实世界多中心注册ADOREG的分析
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-02-20 DOI: 10.1016/j.ejca.2026.116582
Konstantinos Lallas , Lena Nanz , Selma Ugurel , Peter Mohr , Friedegund Meier , Michael Weichenthal , Imke von Wasielewski , Patrick Terheyden , Jessica Hassel , Alexander Kreuter , Rudolf Herbst , Anja Gesierich , Claudia Pföhler , Ralf Gutzmer , Julia Welzel , Christoffer Gebhardt , Sebastian Haferkamp , Jens Ulrich , Martin Kaatz , Frank Meiss , Ulrike Leiter
{"title":"Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG","authors":"Konstantinos Lallas ,&nbsp;Lena Nanz ,&nbsp;Selma Ugurel ,&nbsp;Peter Mohr ,&nbsp;Friedegund Meier ,&nbsp;Michael Weichenthal ,&nbsp;Imke von Wasielewski ,&nbsp;Patrick Terheyden ,&nbsp;Jessica Hassel ,&nbsp;Alexander Kreuter ,&nbsp;Rudolf Herbst ,&nbsp;Anja Gesierich ,&nbsp;Claudia Pföhler ,&nbsp;Ralf Gutzmer ,&nbsp;Julia Welzel ,&nbsp;Christoffer Gebhardt ,&nbsp;Sebastian Haferkamp ,&nbsp;Jens Ulrich ,&nbsp;Martin Kaatz ,&nbsp;Frank Meiss ,&nbsp;Ulrike Leiter","doi":"10.1016/j.ejca.2026.116582","DOIUrl":"10.1016/j.ejca.2026.116582","url":null,"abstract":"<div><h3>Purpose</h3><div>Data on treatment approaches in geriatric melanoma patients are scant. Efficacy of oncologic treatments across age groups, with special focus on immunotherapy, and the impact of comorbidities were analyzed.</div></div><div><h3>Methods</h3><div>A retrospective multicenter cohort study of the ADOREG registry included patients with cutaneous melanoma, who received oncological drugs at German skin cancer centers between 2013 and 2023. Outcomes were objective response rate (ORR), progression-free survival (PFS), melanoma-specific survival (MSS), toxicities and reasons for treatment discontinuation. Age groups were prespecified as &lt; 75 vs ≥ 75 years (geriatric), comorbidities were summarized by Charlson-Comorbidity-Index (CCI). Comparisons across groups were conducted with X<sup>2</sup>-test, survival outcomes were compared via log-rank tests.</div></div><div><h3>Results</h3><div>Of 14,356 melanoma patients, 8213 met the inclusion criteria, 6063 and 2150 were &lt; 75 and ≥ 75 years old, respectively. Among the 3646 patients with metastatic disease, older patients received fewer treatment lines and were less likely to undergo surgery, radiotherapy and systemic therapy. However, efficacy of any first-line treatment did not differ between both age groups (p = 0.306). Immunotherapy selection at any line was similar in both groups (p = 0.109), but geriatrics were treated mainly with first-line anti-PD1 monotherapy, whereas combination ICIs was preferred in younger patients. Efficacy was not impaired (PFS and MSS: p &gt; 0.05), while toxicity rates were lower. This pattern persisted across CCI categories.</div></div><div><h3>Conclusion</h3><div>Age influenced treatment selection in melanoma patients. However, in geriatric patients, efficacy was not impaired, and a balanced toxicity profile was noticed, particularly for immunotherapy. Future studies considering biological age and impairment by comorbidities seems important to assess individualized treatment approaches.</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116582"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147303855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of tumour infiltrating lymphocytes and metabolic activity of the spleen derived from [18F]FDG PET/CT in predicting axillary pathologic complete response in clinically node-positive breast cancer after neoadjuvant chemotherapy [18F]FDG PET/CT显示的肿瘤浸润淋巴细胞和脾脏代谢活性在预测临床淋巴结阳性乳腺癌新辅助化疗后腋窝病理完全缓解中的作用
IF 7.1 1区 医学
European Journal of Cancer Pub Date : 2026-03-26 Epub Date: 2026-03-27 DOI: 10.1016/j.ejca.2026.116348
M. Lenaerts , L. Kooreman , F.J.G. van Amstel , C.C.P. Adang , F.M. Mottaghy , P.J. van Diest , J.M. Simons , E.J.T. Luiten , C.C. van der Pol , L.B. Koppert , M.L. Smidt , T.J.A. van Nijnatten
{"title":"The role of tumour infiltrating lymphocytes and metabolic activity of the spleen derived from [18F]FDG PET/CT in predicting axillary pathologic complete response in clinically node-positive breast cancer after neoadjuvant chemotherapy","authors":"M. Lenaerts ,&nbsp;L. Kooreman ,&nbsp;F.J.G. van Amstel ,&nbsp;C.C.P. Adang ,&nbsp;F.M. Mottaghy ,&nbsp;P.J. van Diest ,&nbsp;J.M. Simons ,&nbsp;E.J.T. Luiten ,&nbsp;C.C. van der Pol ,&nbsp;L.B. Koppert ,&nbsp;M.L. Smidt ,&nbsp;T.J.A. van Nijnatten","doi":"10.1016/j.ejca.2026.116348","DOIUrl":"10.1016/j.ejca.2026.116348","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"237 ","pages":"Article 116348"},"PeriodicalIF":7.1,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147554203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书